Acute changes in immune biomarkers under low‐ and moderate‐dose alcohol in light and heavy drinkers: A randomized, placebo‐controlled trial

Ähnliche Einträge

• Embracing the complexity of alcohol's immunomodulatory effects: Commentary on Monnig, Lamb, Clark, and Monti—“Acute changes in immune biomarkers under low and moderate dose alcohol in light and heavy drinkers: A randomized, placebo‐controlled trial”
  von: Erica N. Grodin, et al.
  Veröffentlicht: (2025)
• High‐ and low‐dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes: A randomized control trial
  von: Jason D. Robinson, et al.
  Veröffentlicht: (2025)
• Moderation of treatment outcomes by polygenic risk for alcohol‐related traits in placebo‐controlled trials of topiramate
  von: Henry R. Kranzler, et al.
  Veröffentlicht: (2025)
• Correction to “Feasibility and acceptability of maternal choline supplementation in heavy drinking pregnant women: a randomized, double‐blind, placebo‐controlled clinical trial”
  Veröffentlicht: (2024)
• Effect of the GLP ‐1 receptor agonist exenatide on pro‐inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double‐blinded, placebo‐controlled clinical trial
  von: Malthe E. B. Hviid, et al.
  Veröffentlicht: (2025)